Evidence map›Paper›PMID 38511004›Full record

ArticleFrontiers in microbiology2024

Surveillance of Nipah virus in

R Balasubramanian, Sreelekshmy Mohandas, Ullas P Thankappan, Anita Shete, Dilip Patil, Kannan Sabarinath, Basavaraj Mathapati, Rima Sahay, Deepak Patil, Pragya D Yadav

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Nipah virus survey inFrontiers in microbiology · 2024
    Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

R Balasubramanian *Field Unit, ICMR-National Institute of Virology, Alappuzha, India.
Sreelekshmy Mohandas *Maximum Containment Facility, ICMR-National Institute of Virology, Pune, India.
Ullas P ThankappanEncephalitis Group, ICMR-National Institute of Virology, Pune, India.
Anita SheteMaximum Containment Facility, ICMR-National Institute of Virology, Pune, India.
Dilip PatilAnimal House, ICMR-National Institute of Virology, Pune, India.
Kannan SabarinathMaximum Containment Facility, ICMR-National Institute of Virology, Pune, India.
Basavaraj MathapatiField Unit, ICMR-National Institute of Virology, Dibrugarh, India.
Rima SahayMaximum Containment Facility, ICMR-National Institute of Virology, Pune, India.
Deepak PatilMaximum Containment Facility, ICMR-National Institute of Virology, Pune, India.
Pragya D YadavMaximum Containment Facility, ICMR-National Institute of Virology, Pune, India.
ICMR-National Institute of Virology · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Since 2018, the Indian state of Kerala has reported four Nipah virus (NiV) disease outbreaks, raising concerns about NiV spillover from bats to the human population. Considering this, a cross-sectional study was undertaken in the Methods: Throat swabs, rectal swabs, and organ samples were collected from bats to test for NiV using the real-time reverse transcriptase polymerase chain reaction (RT-PCR), while serum samples were screened for anti-Nipah IgG antibodies through ELISA. Results: An overall seroprevalence of 20.9% was observed in 272 Discussion: The findings of the study caution that there is a spillover risk in the region and necessary precautions should be taken.

Indexed as

IndiaKeralaNipah virusPteropus mediusseroprevalence

Identifiers

PMID38511004
PMCPMC10951996
OpenAlexW4392516973

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.